CN1149078C - 治疗慢性胃肠道炎症的制剂 - Google Patents

治疗慢性胃肠道炎症的制剂 Download PDF

Info

Publication number
CN1149078C
CN1149078C CNB988135329A CN98813532A CN1149078C CN 1149078 C CN1149078 C CN 1149078C CN B988135329 A CNB988135329 A CN B988135329A CN 98813532 A CN98813532 A CN 98813532A CN 1149078 C CN1149078 C CN 1149078C
Authority
CN
China
Prior art keywords
budesonide
oil
oral formulations
dose
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB988135329A
Other languages
English (en)
Chinese (zh)
Other versions
CN1284869A (zh
Inventor
乔尔·博朗尼克
艾伦·斯图尔特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN1284869A publication Critical patent/CN1284869A/zh
Application granted granted Critical
Publication of CN1149078C publication Critical patent/CN1149078C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CNB988135329A 1998-02-09 1998-02-09 治疗慢性胃肠道炎症的制剂 Expired - Fee Related CN1149078C (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/002265 WO1999039699A1 (en) 1998-02-09 1998-02-09 Treatment of chronic inflammatory disorders of the gastrointestinal tract

Publications (2)

Publication Number Publication Date
CN1284869A CN1284869A (zh) 2001-02-21
CN1149078C true CN1149078C (zh) 2004-05-12

Family

ID=22266344

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB988135329A Expired - Fee Related CN1149078C (zh) 1998-02-09 1998-02-09 治疗慢性胃肠道炎症的制剂

Country Status (9)

Country Link
EP (1) EP1052977A4 (enExample)
JP (1) JP2002502812A (enExample)
KR (1) KR20010040646A (enExample)
CN (1) CN1149078C (enExample)
AU (1) AU735084B2 (enExample)
CA (1) CA2320087C (enExample)
IL (1) IL137598A (enExample)
SE (1) SE0002831L (enExample)
WO (1) WO1999039699A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100333727C (zh) * 2004-11-25 2007-08-29 天津药业研究院有限公司 布地奈德靶向微丸及其制备方法
MD2852C2 (ro) * 2005-03-28 2006-04-30 Георге АНГЕЛИЧ Utilizarea budesonidei pentru tratamentul ascitei rezistente la pacienţii cu ciroză hepatică
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
KR101434706B1 (ko) * 2007-02-16 2014-08-26 아스카 세이야쿠 가부시키가이샤 미립자 유성 현탁액을 포함하는 의약 조성물
CA2704949A1 (en) 2007-11-13 2009-05-22 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20090131386A1 (en) 2007-11-13 2009-05-21 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
CZ288032B6 (cs) * 1991-12-18 2001-04-11 Aktiebolaget Astra Farmaceutický prostředek pro podání inhalací
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
GB9412394D0 (en) * 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
CN1088584C (zh) * 1996-08-02 2002-08-07 久光制药株式会社 口服制剂用胶囊及口服胶囊制剂
KR100219918B1 (ko) * 1997-07-03 1999-09-01 김윤 대장선택적 약물전달용 조성물

Also Published As

Publication number Publication date
AU735084B2 (en) 2001-06-28
JP2002502812A (ja) 2002-01-29
SE0002831D0 (sv) 2000-08-07
IL137598A (en) 2005-09-25
WO1999039699A1 (en) 1999-08-12
SE0002831L (sv) 2000-09-28
CA2320087C (en) 2006-12-19
KR20010040646A (ko) 2001-05-15
AU6320098A (en) 1999-08-23
IL137598A0 (en) 2001-07-24
EP1052977A4 (en) 2006-07-12
CN1284869A (zh) 2001-02-21
EP1052977A1 (en) 2000-11-22
CA2320087A1 (en) 1999-08-12

Similar Documents

Publication Publication Date Title
US5863910A (en) Treatment of chronic inflammatory disorders of the gastrointestinal tract
JP7688360B2 (ja) 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用
US20200188304A1 (en) Testosterone undecanoate compositions
KR101809305B1 (ko) 다중미립자 l-멘톨 제제 및 관련 방법
US8080528B2 (en) Compositions and methods for treatment of cachexia
JP2019528272A5 (enExample)
CN107007616A (zh) 反义组合物及其制备和使用方法
CN1149078C (zh) 治疗慢性胃肠道炎症的制剂
CN104220076A (zh) 用于治疗呈现至少一种炎性组分的肠道疾病的方法
CN1361694A (zh) 粘膜吸收甘草甜素制剂
CN111419800B (zh) 用于治疗红斑狼疮的药物制剂及其制备方法
JP2006517942A (ja) 動物の免疫を向上するためのシステアミンを含む組成物
WO2023135595A1 (en) Combinations with psilocybin for treating gastrointestinal diseases or disorders
CA2721728A1 (en) Treatment of inflammatory bowel disease with 6-mercaptopurine
JP4326696B2 (ja) 糸球体腎炎の治療のための方法および手段
CN1172433A (zh) 胃溃宁制剂
CN1088357C (zh) 5－硝基咪唑衍生物微粒
CN1270776C (zh) 治疗粘膜溃疡的药物组合物，其制备和用途
JP2008526773A (ja) ベクロメタゾンジプロピオネート及びプレドニゾンでの、移植片対宿主病及び白血病の治療
JP2008526773A5 (enExample)
CN114599347B (zh) 治疗肾上腺皮质癌与库欣综合征的口服施用的包含米托坦的药物组合物
JP2003055202A (ja) 炎症性腸疾患の予防・治療剤
US20220304937A1 (en) Pediatric formulation
AU2015238807B2 (en) Multiparticulate l-menthol formulations and related methods
JP2024510051A (ja) 生理活性物質の経口用ナノ粒子及びその製造方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040512

Termination date: 20160209

CF01 Termination of patent right due to non-payment of annual fee